IP Library › Assignment 067535/0539
Patent Assignment
Reel/Frame 067535/0539

Assignment of Assignor's Interest

Recorded: 2024-05-28 Pages: 14
Assignor
MAGENTA THERAPEUTICS, INC.
Executed: 2023-07-20
Assignee
VOR BIOPHARMA INC.
100 CAMBRIDGE PARK DR., SUITE 400, CAMBRIDGE, MASSACHUSETTS, 02140
Covered Properties (46)
Compositions and Methods for the Depletion of Cells
Application: 16/310,738 →
Publication: US 2019/0328901
Methods for the Depletion of Cells
Application: 16/289,388 →
Publication: US 2019/0192682
Compositions and Methods for the Depletion of Cells
Application: 16/853,619 →
Publication: US 2020/0376134
Compositions and Methods for the Depletion of Endogenous CD135+ Cells Prior to Hematopoietic Stem Cell Transplant Therapy
Application: 62/351,778 →
Compositions and Methods for the Depletion of Endogenous CD135+ Cells Prior to Hematopoietic Stem Cell Transplant Therapy
Application: 62/437,756 →
Compositions and Methods for the Depletion of Endogenous CD135+ Cells Prior to Hematopoietic Stem Cell Transplant Therapy
Application: 62/448,768 →
Anti-CD45 Antibodies and Conjugates Thereof
Application: 62/753,002 →
Anti-CD45 Antibodies and Conjugates Thereof
Application: 62/774,006 →
Anti-CD45 Antibodies and Conjugates Thereof
Application: 62/807,582 →
Methods for Allogeneic Hematopoietic Stem Cell Transplantation
Application: 17/244,864 →
Publication: US 2021/0379195
Methods for Allogeneic Hematopoietic Stem Cell Transplantation
Application: 62/752,828 →
Methods for Allogeneic Hematopoietic Stem Cell Transplantation
Application: 62/773,873 →
Methods for Allogeneic Hematopoietic Stem Cell Transplantation
Application: 62/882,362 →
Use of an Anti-CD45 Antibody Drug Conjugate (Adc) in Cell Therapy
Application: 17/368,815 →
Publication: US 2022/0062339
Use of an Anti-CD45 Antibody Drug Conjugate (Adc) in Cell Therapy
Application: 62/789,462 →
Use of an Anti-CD45 Antibody Drug Conjugate (Adc) in Cell Therapy
Application: 62/845,829 →
Methods of Use of Anti-CD45 Antibodies and Conjugates Thereof
Application: 17/452,028 →
Publication: US 2022/0267441
Anti-CD45 Antibodies and Conjugates Thereof
Application: 63/046,046 →
Conditioning Methods for Gene Therapy
Application: 17/507,456 →
Publication: US 2022/0175946
Conditioning Methods for Gene Therapy
Application: 62/838,278 →
Conditioning Methods for Gene Therapy
Application: 62/944,925 →
Anti-CD45 Antibody Drug Conjugates and Uses Thereof
Application: 17/508,641 →
Publication: US 2022/0175951
Anti-CD45 Antibody Drug Conjugates and Uses Thereof
Application: 62/838,280 →
Methods and Compositions for Treating Autoimmune Diseases
Application: 17/457,583 →
Publication: US 2022/0273811
Methods and Compositions for Treating Autoimmune Diseases
Application: 62/857,232 →
Methods and Compositions for Treating Autoimmune Diseases
Application: 62/863,141 →
Methods and Compositions for Treating Autoimmune Diseases
Application: 62/882,310 →
Methods and Compositions for Treating Autoimmune Diseases
Application: 62/933,279 →
Methods and Compositions for Treating Autoimmune Diseases
Application: 62/944,988 →
Methods and Compositions for Treating Autoimmune Diseases
Application: 62/968,870 →
Methods and Compositions for Treating Autoimmune Diseases
Application: 63/030,860 →
Compositions and Methods for Allogeneic Transplantation
Application: 17/820,540 →
Publication: US 2023/0390412
Compositions and Methods for Allogeneic Transplantation
Application: 62/978,141 →
Compositions and Methods for Allogeneic Transplantation
Application: 63/062,845 →
Therapeutic Methods Using Antibody Drug Conjugates (Adcs)
Application: 17/111,816 →
Publication: US 2021/0283267
THERAPEUTIC METHODS USING ANTIBODY DRUG CONJUGATES (ADCs)
Application: 62/682,154 →
Therapeutic Methods Using Antibody Drug Conjugates (Adcs)
Application: 62/841,702 →
Compositions and Methods for the Depletion of Cells
Anti-CD45 Antibodies and Conjugates Thereof
Methods for Allogeneic Hematopoietic Stem Cell Transplantation
Use of an Anti-CD45 Antibody Drug Conjugate (Adc) in Cell Therapy
Anti-CD45 Antibodies and Conjugates Thereof
Conditioning Methods for Gene Therapy
Anti-CD45 Antibody Drug Conjugates and Uses Thereof
Methods and Compositions for Treating Autoimmune Diseases
Compositions and Methods for Allogeneic Transplantation
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 23, 2018
From: NIXON, ANDREW; MORROW, DWIGHT; HARTIGAN, ADAM
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 045322/0976 →
Assignment of Assignor's Interest Apr 9, 2019
From: BOITANO, ANTHONY
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 048838/0188 →
Assignment of Assignor's Interest Apr 9, 2019
From: PALCHAUDHURI, RAHUL
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 048838/0178 →
Assignment of Assignor's Interest May 2, 2019
From: NIXON, ANDREW; MORROW, DWIGHT; HARTIGAN, ADAM
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 049064/0179 →
Assignment of Assignor's Interest Jun 5, 2019
From: COOKE, MICHAEL; PROCTOR, JENNIFER LYNN; MCDONAGH, CHARLOTTE FENTON
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 049386/0328 →
Assignment of Assignor's Interest Oct 30, 2019
From: PALCHAUDHURI, RAHUL; PEARSE, BRADLEY R.; ADAMS, HILLARY; MCDONOUGH, SEAN
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 050869/0083 →
Assignment of Assignor's Interest Oct 30, 2019
From: PALCHAUDHURI, RAHUL; PROCTOR, JENNIFER LYNN; GILLARD, GEOFFREY O.; BOITANO, ANTHONY
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 050869/0374 →
Assignment of Assignor's Interest Oct 31, 2019
From: GIRAFPHARMA LLC
To: NUVATION BIO INC.
Reel/Frame 050884/0853 →
Assignment of Assignor's Interest Jan 7, 2020
From: GILLARD, GEOFFREY O.; BOITANO, ANTHONY
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 051438/0417 →
Assignment of Assignor's Interest Apr 13, 2020
From: MCDONAGH, CHARLOTTE FENTON
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 052384/0304 →
Assignment of Assignor's Interest Apr 20, 2020
From: BOITANO, ANTHONY
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 052447/0746 →
Assignment of Assignor's Interest Apr 21, 2020
From: PALCHAUDHURI, RAHUL
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 052458/0586 →
Assignment of Assignor's Interest Apr 22, 2020
From: PEARSE, BRADLEY R.
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 052468/0304 →
Assignment of Assignor's Interest Apr 23, 2020
From: PALCHAUDHURI, RAHUL
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 052472/0556 →
Assignment of Assignor's Interest Apr 23, 2020
From: PEARSE, BRADLEY R.
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 052472/0487 →
Assignment of Assignor's Interest Apr 23, 2020
From: GILLARD, GEOFFREY O.
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 052472/0325 →
Assignment of Assignor's Interest Apr 23, 2020
From: BOITANO, ANTHONY
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 052472/0288 →
Assignment of Assignor's Interest Apr 24, 2020
From: COOKE, MICHAEL
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 052487/0411 →
Assignment of Assignor's Interest Jun 2, 2020
From: GILLARD, GEOFFREY O.; PROCTOR, JENNIFER LYNN; BOITANO, ANTHONY; COOKE, MICHAEL
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 052817/0594 →
Assignment of Assignor's Interest Jun 4, 2020
From: GILLARD, GEOFFREY O.; PROCTOR, JENNIFER LYNN; BOITANO, ANTHONY; COOKE, MICHAEL
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 052845/0419 →
Assignment of Assignor's Interest Oct 29, 2020
From: MCDONAGH, CHARLOTTE
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 054215/0178 →
Assignment of Assignor's Interest Oct 29, 2020
From: PANWAR, RAJIV
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 054215/0642 →
Assignment of Assignor's Interest Oct 29, 2020
From: PEARSE, BRADLEY
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 054215/0994 →
Assignment of Assignor's Interest Oct 29, 2020
From: WIDBOOM, PAUL FREDRICK
To: ADIMAB, LLC
Reel/Frame 054210/0425 →
Assignment of Assignor's Interest Oct 29, 2020
From: BOITANO, ANTHONY
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 054209/0982 →